Patent US4613613A successfully refreshed from Google Patents.
US4613613A
Expired / Lapsed
US
⏱️ 0.0 years remaining
γ-butyrolactone derivatives, process for preparing the same and immunomodulating compositions containing the same as active ingredients
Assignee: Mitsubishi Chemical America Inc
•
Filing: 1984-09-06
•
Granted: 1986-09-23
•
Expires: 2004-09-06
Abstract
Abstract A γ-butyrolactone derivative represented by the following formula: ##STR1## wherein R 1 represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a phenyl group; R 2 and R 3 may be the same or different and each represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group, a phenyl group, a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, an alkoxy group, a nitro group, an amino group, an alkyl group having 1-4 carbon atoms, a nitrile group and an alkoxycarbonyl group; R 2 and R 3 may be linked to form an alkylene group having 4-6 carbon atoms; X represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group or a substituent represented by the formula ##STR2## (wherein R 4 represents a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group, a phenyl group or a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, an alkoxy group, a nitro group, an alkylthio group, a nitrile group, an alkoxycarbonyl group and an alkyl group having 1-4 carbon atoms) or a salt thereof. The invention also provides an immunomodulating composition wherein the aforedescribed compound is the active component.
Inventors
- 👤 Tomei Oguri
- 👤 Yasuhiro Morinaka
- 👤 Shuichiro Kadowaki
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 15:24
CPC Classifications
C; C07; C07D; C07D307/00; C07D307/02; C07D307/26; C07D307/30; C07D307/32; C07D307/33; A; A61; A61P; A61P29/00; C07D307/34; C07D307/56; C07D307/58; C07D307/94
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
249 words
A γ-butyrolactone derivative represented by the following formula: ##STR144## wherein R 1 represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a phenyl group; R 2 and R 3 may be the same or different and each represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group, a phenyl group, a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, an alkoxy group having 1-5 carbon atoms, a nitro group, an amino group, an alkyl group having 1-4 carbon atoms, a nitrile group and an alkoxycarbonyl group having 2-6 carbon atoms; R 2 and R 3 may be linked to form an alkylene group having 4-6 carbon atoms; X represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group or a substituent represented by the formula ##STR145## wherein R 4 represents a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group, a phenyl group or a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, an alkoxy group having 1-5 carbon atoms, a nitro group, an alkylthio group having 1-5 carbon atoms, a nitrile group, an alkoxycarbonyl group having 2-6 carbon atoms and an alkyl group having 1-4 carbon atoms or a salt thereof.
Claim 2
Dependent Claim
249 words
A γ-butyrolactone derivative represented by the following formula: ##STR144## wherein R 1 represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a phenyl group; R 2 and R 3 may be the same or different and each represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group, a phenyl group, a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, an alkoxy group having 1-5 carbon atoms, a nitro group, an amino group, an alkyl group having 1-4 carbon atoms, a nitrile group and an alkoxycarbonyl group having 2-6 carbon atoms; R 2 and R 3 may be linked to form an alkylene group having 4-6 carbon atoms; X represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group or a substituent represented by the formula ##STR145## wherein R 4 represents a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group, a phenyl group or a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, an alkoxy group having 1-5 carbon atoms, a nitro group, an alkylthio group having 1-5 carbon atoms, a nitrile group, an alkoxycarbonyl group having 2-6 carbon atoms and an alkyl group having 1-4 carbon atoms or a salt thereof.
Claim 3
Dependent Claim
111 words
The γ-butyrolactone derivative according to claim 1, wherein, R 1 is a hydrogen atom, a straight alkyl group having 1-4 carbon atoms or a phenyl group, one of R 2 and R 3 is a hydrogen atom and the other is a hydrogen atom, a substituted or unsubstituted phenyl group, a benzyl group or a cyclohexyl group or both are jointed to form an alkylene group having 4 or 5 carbon atoms, X is a hydrogen atom, a straight alkyl group having 1-4 carbon atoms, a cyclohexyl group, a benzyl group, a benzylcarbonyl group, a straight or branched alkanoyl group having 2-9 carbon atoms or a substituted or unsubstituted benzoyl group.
Claim 4
Dependent Claim
84 words
The γ-butyrolactone derivative according to claim 2, wherein, R 1 is a hydrogen atom or a phenyl group, one of R 2 and R 3 is a hydrogen atom and the other is a hydrogen atom, a substituted or unsubstituted phenyl group or cyclohexyl group, X is a hydrogen atom, a straight alkyl group having 1-4 carbon atoms, a cyclohexyl group, a benzyl group, a benzylcarbonyl group, a straight or branched alkanoyl group having 2-7 carbon atoms or a substituted or unsubstituted benzoyl group.
Claim 5
Dependent Claim
54 words
The γ-butyrolactone derivative according to claim 3, wherein, R 1 is a hydrogen atom, one of R 2 and R 3 is a hydrogen atom and the other is a substituted or unsubstituted phenyl group, X is a straight or branched alkanoyl group having 2-7 carbon atoms of a substituted of unsubstituted benzoyl group.
Claim 6
Dependent Claim
267 words
An immunomodulating composition which comprises a pharmaceutically acceptable carrier and as an active ingredient an immunomodulating effective amount of a γ-butyrolactone derivative represented by the formula ##STR146## wherein R 1 represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a phenyl group; R 2 and R 3 may be the same or different and each represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group, a phenyl group, a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, an alkoxy group having 1-5 carbon atoms, a nitro group, an amino group, an alkyl group having 1-4 carbon atoms, a nitrile group and an alkoxycarbonyl group having 2-6 carbon atoms; R 2 and R 3 may be linked to form an alkylene group having 4-6 carbon atoms; X represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group or a substituent represented by the formula ##STR147## wherein R 4 represents a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group, a phenyl group or a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, an alkoxy group having 1-5 carbon atoms, a nitro group, an alkylthio group having 1-5 carbon atoms, a nitrile group, an alkoxycarbonyl group having 2-6 carbon atoms and an alkyl group having 1-4 carbon atoms or a salt thereof.
Claim 7
Dependent Claim
267 words
An immunomodulating composition which comprises a pharmaceutically acceptable carrier and as an active ingredient an immunomodulating effective amount of a γ-butyrolactone derivative represented by the formula ##STR146## wherein R 1 represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a phenyl group; R 2 and R 3 may be the same or different and each represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group, a phenyl group, a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, an alkoxy group having 1-5 carbon atoms, a nitro group, an amino group, an alkyl group having 1-4 carbon atoms, a nitrile group and an alkoxycarbonyl group having 2-6 carbon atoms; R 2 and R 3 may be linked to form an alkylene group having 4-6 carbon atoms; X represents a hydrogen atom, a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group or a substituent represented by the formula ##STR147## wherein R 4 represents a straight or branched alkyl group having 1-8 carbon atoms, a cycloalkyl group having 3-10 carbon atoms, a benzyl group, a phenyl group or a phenyl group substituted with a substituent selected from the group consisting of a halogen atom, an alkoxy group having 1-5 carbon atoms, a nitro group, an alkylthio group having 1-5 carbon atoms, a nitrile group, an alkoxycarbonyl group having 2-6 carbon atoms and an alkyl group having 1-4 carbon atoms or a salt thereof.
Claim 8
Dependent Claim
111 words
The immunomodulating composition according to claim 5, wherein, R 1 is a hydrogen atom, a straight alkyl group having 1-4 carbon atoms or a phenyl group, one of R 2 and R 3 is a hydrogen atom and the other is a hydrogen atom, a substituted or unsubstituted phenyl group, a benzyl group or a cyclohexyl group or both are jointed to form an alkylene group having 4 or 5 carbon atoms, X is a hydrogen atom, a straight alkyl group having 1-4 carbon atoms, a cyclohexyl group, a benzyl group, a benzylcarbonyl group, a straight or branched alkanoyl group having 2-9 carbon atoms or a substituted or unsubstituted benzoyl group.
Claim 9
Dependent Claim
84 words
The immunomodulating composition according to claim 6, wherein, R 1 is a hydrogen atom or a phenyl group, one of R 2 and R 3 is a hydrogen atom and the other is a hydrogen atom, a substituted or unsubstituted phenyl group or cyclohexyl group, X is a hydrogen atom, a straight alkyl group having 1-4 carbon atoms, a cyclohexyl group, a benzyl group, a benzylcarbonyl group, a straight or branched alkanoyl group having 2-7 carbon atoms or a substituted or unsubstituted benzoyl group.
Claim 10
Dependent Claim
54 words
The immunomodulating composition according to claim 7, wherein, R 1 is a hydrogen atom, one of R 2 and R 3 is a hydrogen atom and the other is a substituted or unsubstituted phenyl group, X is a straight or branched alkanoyl group having 2-7 carbon atoms or a substituted or unsubstituted benzoyl group.
References Cited (Backward Citations)
US3328415A
Cited
GB1075456A
Cited
DE1920176A1
Cited
JPS57183778A
Cited
JPS588044A
Cited
JPS5879989A
Cited
GB2114571A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-09-22 | 1990-03-24 | 1990-09-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-09-22 | 1994-03-24 | 1994-09-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-09-22 | 1998-03-24 | 1998-09-23 | $7700.00 | Window Closed / Lapsed |